Human retinoblastoma binding protein 9 (RBBP9) is an interacting partner of the
retinoblastoma susceptibility protein (Rb). RBBP9 is a tumor-associated protein required for …

The retinoblastoma binding protein 6 (RBBP6) proteins (also called P-53 Associated Cell
Testis Derived (PACT)) are highly upregulated in esophageal cancer and enhance the …

Pancreatic cancer is one of the most lethal malignancies. To discover functionally relevant
modulators of pancreatic neoplasia, we performed activity-based proteomic profiling on …

As a step towards better integrating protein three-dimensional (3D) structural information in
cancer systems biology, the Northeast Structural Genomics Consortium (NESG)(www. nesg …

The past decade has seen re-markable advances in the fields of both proteomics and
genomics. In addition to basic technical advances that have led to an increased volume of …

Using a NotI linking clone NR-025 as a probe, we isolated a novel putative member of the
RB binding protein family, namely a human retinoblastoma binding protein 2 homologue …

A 2860-bp cDNA was isolated from a human fetal brain cDNA library by high throughput
cDNA sequencing, which encodes a putative protein with 186 amino acids. The putative …

We have previously isolated cDNA of a novel protein (RBQ-1, HGMW-approved symbol
RBBP6) that binds to the retinoblastoma gene product (pRB). Total nucleotide sequence of …

Regulators of the tumour suppressor protein, p53 are promising anti-cancer drug
candidates. The retinoblastoma binding protein 6 (RBBP6), a p53 negative regulator, has …

Neuroendocrine tumors (NETs), which can have survival rates as low as 4%, currently have
limited therapeutic interventions available highlighting the dire need for the identification of …